Catheter to thermally classify atherosclerotic plaque

Award Information
Agency:
Department of Health and Human Services
Amount:
$0.00
Program:
SBIR
Contract:
2R44HL067473-02A2
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
N/A
Award Year:
2004
Phase:
Phase I
Agency Tracking Number:
HL067473
Solicitation Topic Code:
N/A
Small Business Information
ACCUMED SYSTEMS, INC.
6109 JACKSON ROAD, ANN ARBOR, MI, 48103
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 JOSEPH KOROTKO
 (734) 930-0461
 JKOROTKO@ACCUMEDSYSTEMSINC.COM
Business Contact
 JAMES KOERT
Phone: (734) 930-0461
Email: JKOERT@ACCUMEDSYSTEMSINC.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The purpose of this study will be to detect the prevalence and prognostic value of plaque temperature heterogeneity in diabetic patients undergoing stent implantation. The objective is to develop and commercialize an intraluminal Thermal Sensing System (TSS) for taking surface temperature measurements of atherosclerotic plaque lesions within the walls of coronary arteries with the goal that current and future means to prevent coronary events can be implemented selectively. The system comprises an invasive catheter and an external instrument. The device has been validated in vitro and in vivo. A pilot human study involving patients undergoing angioplasty for medically indicated reasons was completed successfully. Specific Aims for the proposed SBIR Phase II are: [1] Advance the current intraluminal TSS toward a commercially viable product - change to thermocouples, improve catheter flexibility, reduce sensing element profile, integrate an occlusion feature - followed by revalidation of System safety and performance. [2] Demonstrate in a human clinical trial the predictive value of plaque surface temperature for future ischemic events and validate the performance of the TSS. After this grant we have plans in place to commercialize the technology including design for manufacturability, additional clinical studies, and a market development strategy for this exciting and useful new diagnostic device.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government